Breaking
Friday, June 19, 2026

Clinical Trials

🌏 NMPA Page 2

NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.

Showing 13–24 of 75 articles

High impact AnalysisJun 5, 2026

Ecosystem Over Geography: Life Sciences Location Strategy in APAC

EMA · 5 min

Dr. Yuki Tanaka
High impact AnalysisJun 4, 2026

Helus Pharma to Participate in the Jefferies Global Healthcare Conference: Strategic Implications for Analysts and BD Teams

4 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's

FDA · Alzheimer's disease · 4 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

PREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI

FDA · 5 min

Dr. Yuki Tanaka
High impact AnalysisJun 3, 2026

Acclinate and HCN Global Forge Strategic Partnership to Enhance Clinical Research Diversity

6 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

The Pulse of ACC: Honoring Eugene Braunwald and Shaping Cardiology's Future

hypertrophic cardiomyopathy · 7 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

Illumina's APAC Strategy Under Nilesh Shah: A Competitive Benchmark

7 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

How Medicine Forgot Women: A Missed Opportunity for Asia

9 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements

oncology · 6 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

Newron Pharmaceuticals to Present at Upcoming Investor Conferences

FDA · 7 min

Dr. Yuki Tanaka
Medium impact NewsJun 1, 2026

Pharmaceuticals Market Size and Share Analysis for 2034

3 min

Dr. Yuki Tanaka
Medium impact NewsMay 31, 2026

Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights

2 min

Dr. Yuki Tanaka